AST levels were elevated in all tumor groups but remained within the reference range in the [225Ac]Ac-PSMA-617 and [177Lu]Lu-PSMA-617 treated groups without tumors (Fig. 10). The gene discussed is FOLH1; the disease is neoplasm.